ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994

In Brief: Breast Cancer Stamp Unveiled; Payne Moves To MSK; Survivor To Bike Across U.S.

July 31, 1998

Secret Budget Sessions Ended; HEW Out To Lim. Future NCI Funds

April 2, 1976

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988